Free Shipping on orders over $250
Product Name
B7-33
$165.00
A synthetic relaxin-derived peptide studied for RXFP1 receptor signaling, ERK1/2 pathways, fibroblast biology, and extracellular-matrix regulation.
Research Focus
RXFP1 Signaling • ERK1/2 Pathways • Fibroblast Biology • Extracellular Matrix Research • MMP Signaling • GPCR Research
Research Disclaimer: Avante Peptides products are for laboratory and scientific research only and are not intended for human consumption, veterinary use, clinical application, or therapeutic treatment. All research must be conducted by qualified professionals in appropriate laboratory environments.
B7-33 is a synthetic single-chain research peptide derived from the B-chain of human relaxin-2 (H2 relaxin). It was developed as a simplified peptide analog for investigating signaling associated with the Relaxin Family Peptide Receptor 1 (RXFP1).
Laboratory and preclinical research involving B7-33 has examined RXFP1 receptor activation, ERK1/2 signaling, extracellular matrix regulation, fibroblast biology, matrix metalloproteinase activity, and cellular remodeling pathways. Research indicates that B7-33 exhibits functionally selective signaling, with prominent ERK1/2 activity observed in certain RXFP1-expressing fibroblast models.
B7-33 remains an experimental research compound for studying the relationship between relaxin signaling, GPCR activity, extracellular matrix biology, and cellular remodeling mechanisms.
| Attributes | Value |
|---|---|
| Dimensions | 0.66 × 0.66 × 1.5 in |
| Strength |
10mg |
| Research Focus |
RXFP1 Signaling • ERK1/2 Pathways • Fibroblast Biology • Extracellular Matrix Research • MMP Signaling • GPCR Research |